{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:45:24Z","timestamp":1791146724245,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":462,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"European Commission: Marie Curie Career Integration Grant (MC-CIG)","award":["294098\/Theravac"],"award-info":[{"award-number":["294098\/Theravac"]}]},{"name":"Manfred Lautenschl\u00ef\u00bf\u00bdger Foundation"},{"name":"Melanie and Eduard zur Hausen Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2015,1,1]]},"DOI":"10.1002\/ijc.28968","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T13:12:13Z","timestamp":1399986733000},"page":"212-224","source":"Crossref","is-referenced-by-count":26,"title":["Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design"],"prefix":"10.1002","volume":"136","author":[{"given":"Agnieszka K.","family":"Grabowska","sequence":"first","affiliation":[{"name":"Immunotherapy and -prevention; German Cancer Research Center (DKFZ); Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology; Charit\u00e9 - University Medicine; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika B.","family":"Riemer","sequence":"additional","affiliation":[{"name":"Immunotherapy and -prevention; German Cancer Research Center (DKFZ); Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,27]]},"reference":[{"key":"10.1002\/ijc.28968-BIB0001|ijc28968-cit-0001","first-page":"19","article-title":"Papillomaviruses in human cancer","volume":"5","author":"zur Hausen","year":"1987","journal-title":"Appl Pathol"},{"key":"10.1002\/ijc.28968-BIB0002|ijc28968-cit-0002","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"Suppl 5","key":"10.1002\/ijc.28968-BIB0003|ijc28968-cit-0003","doi-asserted-by":"crossref","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","article-title":"Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis","volume":"30","author":"Gillison","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1002\/ijc.28968-BIB0004|ijc28968-cit-0004","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1002\/ijc.28968-BIB0005|ijc28968-cit-0005","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/ijc.28968-BIB0006|ijc28968-cit-0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/ijc.28968-BIB0007|ijc28968-cit-0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodriguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28968-BIB0008|ijc28968-cit-0008","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: a population-based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1002\/ijc.28968-BIB0009|ijc28968-cit-0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"10.1002\/ijc.28968-BIB0010|ijc28968-cit-0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0378(01)00113-9","article-title":"Immunobiology of papillomavirus infections","volume":"52","author":"Stanley","year":"2001","journal-title":"J Reprod Immunol"},{"key":"10.1002\/ijc.28968-BIB0011|ijc28968-cit-0011","first-page":"636","article-title":"Frequent display of human papillomavirus type 16 E6-specific memory T-helper cells in the healthy population as witness of previous viral encounter","volume":"63","author":"Welters","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0012|ijc28968-cit-0012","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/315706","article-title":"Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens","volume":"182","author":"Nakagawa","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1002\/ijc.28968-BIB0013|ijc28968-cit-0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0168-1702(02)00196-X","article-title":"The status of HPV16-specific T-cell reactivity in health and disease as a guide to HPV vaccine development","volume":"89","author":"der Burg","year":"2002","journal-title":"Virus Res"},{"key":"10.1002\/ijc.28968-BIB0014|ijc28968-cit-0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002371-200003000-00010","article-title":"Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma","volume":"23","author":"Ressing","year":"2000","journal-title":"J Immunother"},{"key":"10.1002\/ijc.28968-BIB0015|ijc28968-cit-0015","first-page":"3676","article-title":"Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)\u221216 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer","volume":"8","author":"Kaufmann","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0016|ijc28968-cit-0016","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","article-title":"ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial","volume":"103","author":"Garcia","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1002\/ijc.28968-BIB0017|ijc28968-cit-0017","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28968-BIB0018|ijc28968-cit-0018","first-page":"373","article-title":"Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression","volume":"1","author":"Bellanger","year":"2011","journal-title":"Am J Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0019|ijc28968-cit-0019","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1874357901206010163","article-title":"Loss of HPV16 E2 protein expression without disruption of the E2 ORF correlates with carcinogenic progression","volume":"6","author":"Xue","year":"2012","journal-title":"Open Virol J"},{"key":"10.1002\/ijc.28968-BIB0020|ijc28968-cit-0020","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1158\/0008-5472.CAN-09-3436","article-title":"A role for HPV16 E5 in cervical carcinogenesis","volume":"70","author":"Maufort","year":"2010","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0021|ijc28968-cit-0021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13402-011-0069-x","article-title":"Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value","volume":"35","author":"Ganguly","year":"2012","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1002\/ijc.28968-BIB0022|ijc28968-cit-0022","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","article-title":"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis","volume":"92","author":"zur Hausen","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28968-BIB0023|ijc28968-cit-0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/156800912799095135","article-title":"Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer","volume":"12","author":"Tan","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1002\/ijc.28968-BIB0024|ijc28968-cit-0024","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/eji.201142205","article-title":"From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help","volume":"42","author":"Wiesel","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1002\/ijc.28968-BIB0025|ijc28968-cit-0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.0105-2896.2006.00389.x","article-title":"Developing and maintaining protective CD8+ memory T cells","volume":"211","author":"Williams","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1002\/ijc.28968-BIB0026|ijc28968-cit-0026","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1158\/0008-5472.CAN-08-4516","article-title":"Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells","volume":"69","author":"Shafer-Weaver","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0027|ijc28968-cit-0027","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","article-title":"CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes","volume":"70","author":"Bos","year":"2010","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0028|ijc28968-cit-0028","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coi.2008.03.007","article-title":"Cytotoxic human CD4(+) T cells","volume":"20","author":"Berg","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1002\/ijc.28968-BIB0029|ijc28968-cit-0029","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellimm.2010.02.008","article-title":"Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy","volume":"262","author":"Brown","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1002\/ijc.28968-BIB0030|ijc28968-cit-0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1874357901206010249","article-title":"The invisible enemy-how human papillomaviruses avoid recognition and clearance by the host immune system","volume":"6","author":"Grabowska","year":"2012","journal-title":"Open Virol J"},{"key":"10.1002\/ijc.28968-BIB0031|ijc28968-cit-0031","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ijc.2910560303","article-title":"Analysis of HLA-DR expression on keratinocytes in cervical neoplasia","volume":"56","author":"Coleman","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28968-BIB0032|ijc28968-cit-0032","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2005.10.039","article-title":"Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma","volume":"78","author":"Zhou","year":"2006","journal-title":"Life Sci"},{"key":"10.1002\/ijc.28968-BIB0033|ijc28968-cit-0033","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1084\/jem.186.1.65","article-title":"Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help","volume":"186","author":"Bennett","year":"1997","journal-title":"J Exp Med"},{"key":"10.1002\/ijc.28968-BIB0034|ijc28968-cit-0034","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00262-008-0525-2","article-title":"A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells","volume":"58","author":"Wang","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1002\/ijc.28968-BIB0035|ijc28968-cit-0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ijc.21459","article-title":"Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease","volume":"118","author":"Welters","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28968-BIB0036|ijc28968-cit-0036","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/1078-0432.CCR-06-2916","article-title":"HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions","volume":"13","author":"Peng","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0037|ijc28968-cit-0037","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C","article-title":"Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes","volume":"91","author":"der Burg","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28968-BIB0038|ijc28968-cit-0038","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1099\/vir.0.82558-0","article-title":"Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women","volume":"88","author":"Gallagher","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1002\/ijc.28968-BIB0039|ijc28968-cit-0039","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1002\/ijc.28968-BIB0040|ijc28968-cit-0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-7580-6-9","article-title":"NetMHCIIpan-2.0-improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure","volume":"6","author":"Nielsen","year":"2010","journal-title":"Immunome Res"},{"key":"10.1002\/ijc.28968-BIB0041|ijc28968-cit-0041","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1002\/ijc.28968-BIB0042|ijc28968-cit-0042","first-page":"472","article-title":"Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects","volume":"62","author":"Jong","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28968-BIB0043|ijc28968-cit-0043","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/CDLI.6.5.751-755.1999","article-title":"Th1 cytokine patterns in cervical human papillomavirus infection","volume":"6","author":"Scott","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/ijc.28968-BIB0044|ijc28968-cit-0044","doi-asserted-by":"crossref","first-page":"24147","DOI":"10.1155\/2007\/24147","article-title":"Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(\u2212) controls","volume":"2007","author":"Bais","year":"2007","journal-title":"Mediators Inflamm"},{"key":"10.1002\/ijc.28968-BIB0045|ijc28968-cit-0045","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1073\/pnas.0704672104","article-title":"Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens","volume":"104","author":"der Burg","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ijc.28968-BIB0046|ijc28968-cit-0046","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00262-011-1092-5","article-title":"CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend","volume":"61","author":"Kim","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1002\/ijc.28968-BIB0047|ijc28968-cit-0047","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03468.x","article-title":"Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia","volume":"150","author":"Visser","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1002\/ijc.28968-BIB0048|ijc28968-cit-0048","doi-asserted-by":"crossref","first-page":"29608","DOI":"10.1074\/jbc.M110.126722","article-title":"A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers","volume":"285","author":"Riemer","year":"2010","journal-title":"J Biol Chem"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.28968","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:18:36Z","timestamp":1625141916000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.28968"}},"subtitle":["Promiscuous HPV T helper epitopes"],"short-title":[],"issued":{"date-parts":[[2014,5,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.28968","relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,27]]}}}